|
Q4 2025
|
43 |
3,021,699 |
2X10.SG, COGT, CGON, TNGX
|
13F-HR
|
2/17/2026 |
000121465926001871 |
|
Q3 2025
|
40 |
2,032,902 |
2X10.SG, CGON, COGT, AMLX
|
13F-HR
|
11/17/2025 |
000121465925016751 |
|
Q2 2025
|
38 |
875,508 |
CGON, TNGX, COGT, OCUL
|
13F-HR
|
8/14/2025 |
000121465925012291 |
|
Q1 2025
|
38 |
733,085 |
CGON, COGT, CNTA, MLYS
|
13F-HR
|
5/14/2025 |
000121465925007553 |
|
Q4 2024
|
38 |
1,023,348 |
CGON, DYN, XNCR, COGT
|
13F-HR
|
2/14/2025 |
000121465925002888 |
|
Q3 2024
|
36 |
1,180,307 |
CGON, DYN, COGT, 2X10.SG
|
13F-HR
|
11/14/2024 |
000121465924019064 |
|
Q2 2024
|
32 |
959,501 |
CGON, DYN, 2X10.SG, SLN
|
13F-HR
|
8/14/2024 |
000121465924014472 |
|
Q1 2024
|
33 |
1,264,901 |
CG ONCOLOGY, INC., DYN, ATXS, SLN
|
13F-HR
|
5/15/2024 |
000121465924009128 |
|
Q4 2023
|
29 |
901,701 |
GPCR, INBX, ICVX, ANTX
|
13F-HR
|
2/14/2024 |
000121465924002612 |
|
Q3 2023
|
26 |
679,112 |
GPCR, COGT, GERN, ANTX
|
13F-HR
|
11/14/2023 |
000121465923014945 |
|
Q2 2023
|
22 |
609,793 |
ISEE, GERN, COGT, VECT
|
13F-HR
|
8/14/2023 |
000121465923011170 |
|
Q1 2023
|
22 |
513,028 |
ISEE, COGT, GERN, MDGL
|
13F-HR
|
5/15/2023 |
000121465923007097 |
|
Q4 2022
|
21 |
566,607 |
ISEE, MDGL, COGT, CBAY
|
13F-HR
|
2/14/2023 |
000121465923002234 |
|
Q3 2022
|
21 |
333,401 |
ISEE, COGT, GERN, VRDN
|
13F-HR
|
11/14/2022 |
000121465922013609 |
|
Q2 2022
|
22 |
235,414 |
COGT, ISEE, GERN, KURA
|
13F-HR
|
8/15/2022 |
000121465922010118 |
|
Q1 2022
|
20 |
249,097 |
ISEE, VRDN, COGT, ACRS
|
13F-HR
|
5/16/2022 |
000121465922007035 |
|
Q4 2021
|
15 |
213,563 |
ISEE, VRDN, COGT, CBAY
|
13F-HR
|
2/17/2022 |
000121465922002872 |